13F-HR 1 w49335e13f-hr.txt REPORT FOR CALENDAR YEAR OR QUARTER ENDED: 3/31/01 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: March 31, 2001 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Grafenauweg 4 Zug, Switzerland CH-6301 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Dubravka Racnjak Title: SIGNING AUTHORITY ------------------ Phone: (41-41) 724-5959 Signature, Place, and Date of Signing: /s/ Dubravka Racnjak Zug, Switzerland May 15, 2001 --------------------- 2 Report Type (Check only one.): [ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Name Biotech Focus S.A. Biotech Invest S.A. Biotech Target S.A. Biotech Growth S.A. 3 Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 24 Form 13F Information Table Value Total: $1,647,307 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Name 1 Biotech Focus S.A. 2 Biotech Invest S.A. 3 Biotech Target S.A. 4 Biotech Growth S.A. 4 BB BIOTECH AG FORM 13F INFORMATION TABLE
----------------------------------------------------------------------------------------------------------------------------------- COLUMN 8: COLUMN 5: VOTING AUTHORITY COLUMN 4: COLUMN 6: COLUMN 1: COLUMN 2: COLUMN 3: VALUE ------------------------ INVESTMENT COLUMN 7: --------------------------- NAME OF ISSUER TITLE OF CLASS CUSIP (X$1,000) SHRS OR SH/ PUT/ DISCRETION OTHER PRN AMT PRN CALL MANAGERS SOLE SHARED NONE ----------------------------------------------------------------------------------------------------------------------------------- Adolor Corp. Common Stock 00724X102 $ 15,115 770,000 SH DEFINED 3 770,000 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Alexion Pharmaceuticals, Inc. Common Stock 015351109 $ 17,658 774,113 SH DEFINED 3 774,113 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Amgen Inc. Common Stock 00075886F1 $ 200,884 3,337,500 SH DEFINED 1 3,337,500 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Aviron Common Stock 05376210 $ 129,056 3,105,286 SH DEFINED 2 3,105,286 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- CV Therapeutics, Inc. Common Stock 12666710 $ 76,466 2,317,147 SH DEFINED 3 2,317,147 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Celgene Corp. Common Stock 151020104 $ 37,875 1,515,000 SH DEFINED 2 1,515,000 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Cell Therapeutics, Inc. Common Stock 150934107 $ 16,514 920,500 SH DEFINED 3 920,500 NONE NONE ---------------------------------------------------------------------------------------------------------------------------------- COR Therapeutics Common Stock 217753102 $ 7,088 315,000 SH DEFINED 2 315,000 NONE NONE Inc. ----------------------------------------------------------------------------------------------------------------------------------- 3-Dimensional Pharmaceuticals, Inc. Common Stock 88554W104 $ 26,512 3,260,970 SH DEFINED 4 3,260,970 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Durect Corporation Common Stock 266605104 $ 17,410 2,302,857 SH DEFINED 4 2,302,857 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Endo Pharmaceuticals, Inc. Common Stock 29264P104 $ 10,147 1,449,500 SH DEFINED 3 1,449,500 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Genentech Common Stock 368710406 $ 131,320 2,600,394 SH DEFINED 1 2,600,394 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- GenVec Inc. Common Stock 37246C109 $ 6,989 1,331,185 SH DEFINED 4 1,331,185 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- IDEC Pharmaceuticals Common Stock 449370105 $ 264,780 6,619,500 SH DEFINED 1 6,619,500 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Imclone Common Stock 45245W109 $ 105,494 3,178,500 SH DEFINED 2 3,178,500 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Medicines Company (The) Common Stock 584688105 $ 57,930 5,204,837 SH DEFINED 4 5,204,837 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- MedImmune Common Stock 584699102 $ 411,041 11,456,000 SH DEFINED 1 11,456,000 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Neurocrine Biosciences Common Stock 64125C109 $ 27,716 1,343,500 SH DEFINED 3 1,343,500 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Pharmacopeia Inc. Common Stock 71713B104 $ 12,167 680,500 SH DEFINED 2 680,500 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Third Wave Technologies Common Stock 88428W108 $ 8,217 1,173,800 SH DEFINED 4 1,173,800 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Transkaryotic Therapies Common Stock 89373510 $ 27,157 1,546,500 SH DEFINED 2 1,546,500 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Trimeris Inc. Common Stock 896263100 $ 23,691 789,700 SH DEFINED 3 789,700 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- United Therapeutics Common Stock 91307C102 $ 11,249 645,000 SH DEFINED 2 645,000 NONE NONE ----------------------------------------------------------------------------------------------------------------------------------- Virologic Common Stock 92823R201 $ 4,831 3,605,004 SH DEFINED 4 3,605,004 NONE NONE COLUMN TOTALS $1,647,307 -----------------------------------------------------------------------------------------------------------------------------------